Consumer-Product Chemical Mixture and Systemic Inflammation: Survey-Weighted Analysis of Seven Urinary Biomarkers in NHANES 2005–2010

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background

Endocrine-disrupting chemicals (EDCs) in consumer products are ubiquitously detected in human biospecimens, yet most epidemiological studies examine single chemicals rather than real-world co-exposures. We evaluated associations between a mixture of seven urinary chemical biomarkers and systemic inflammation.

Methods

Survey-weighted log-log regression models adjusted for age, sex, race/ethnicity, poverty-income ratio, and survey cycle were conducted with Benjamini-Hochberg FDR correction (primary analysis, N=4,864). A sensitivity analysis additionally adjusted for body mass index and smoking status (N=4,494).

Results

In the primary analysis, 5 of 7 chemicals showed significant associations after FDR correction: ethylparaben (β = −0.056, FDR P < .001), propylparaben (β = −0.026, FDR P = .007), bisphenol A (β = +0.052, FDR P = .005), monoethyl phthalate (β = +0.043, FDR P = .002), and monocyclohexyl phthalate (β = +0.215, FDR P = .007). The WQS mixture index was significantly associated with CRP (β = +0.056, 95% CI [0.031, 0.081], P < .001), with monocyclohexyl phthalate carrying the largest mixture weight (0.342). In the BMI- and smoking-adjusted sensitivity analysis, associations attenuated to null for all chemicals, though MCP preserved direction (β = +0.129) and the WQS mixture direction was maintained (β = +0.018). Two multiple imputation sensitivity analyses confirmed that monocyclohexyl phthalate was the only chemical to maintain a positive direction across all four analytical specifications (primary complete-case, BMI-adjusted complete-case, primary-aligned imputation, and BMI-adjusted imputation), reaching statistical significance in three of four specifications and providing convergent evidence of a robust MCP-inflammation association.

Conclusions

The chemical mixture showed a significant collective association with systemic inflammation, consistent with a cumulative pro-inflammatory burden from co-exposure to multiple consumer product chemicals. These findings suggest that regulatory approaches should shift from single-chemical to mixture-based risk assessment frameworks for consumer product safety.

Article activity feed